Changing a cleared device · for AI models that will change

The change-control plan section

If your model will be retrained or updated after it reaches the market, a Predetermined Change Control Plan can authorize those changes in advance. We draft it from your answers, beside the plans the FDA has already authorized in your product code.

From $6,000 · the fee for your device is fixed in writing before work starts

What you get

  • The three parts the FDA's guidance asks for, drafted from your answers: description of modifications, modification protocol with pre-defined acceptance criteria, impact assessment
  • Every sentence citing your own documents or answers, reviewed sentence by sentence; anything unsourced listed, never included
  • The plans the FDA has authorized in your product code, as precedent

PDF and Word. Delivered within submission drafting, or on its own.

How it works

  1. 1

    Send one document, free

    A description of your model and how it will change. A one-page reply in two working days, with a fixed quote.

  2. 2

    Agree the fee and terms

    The fee is fixed in writing; your documents come under a signed confidentiality agreement.

  3. 3

    Receive the section

    Drafted from your answers, reviewed sentence by sentence, with a walkthrough call.

What we need from you

  • What you expect to change in the model, and how often
  • How you would test each change, and your acceptance criteria if you have them
  • Your device description and indications for use

Change-control plans are becoming routine

The FDA’s list of authorized devices with a PCCP holds 240 authorizations across 102 product codes: 29 decided in 2024 and 104 in 2025.

FDA, Predetermined Change Control Plans: List of Authorized Devices with PCCPs, list current as of 2026-10-20, captured 2026-10-26. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions, issued 2025-08-18.

Is it for you?

Right for you if you are asking

“Can our planned model updates be authorized now, instead of filing for each one later?”

Because

  • Retraining or updating the model is part of the product plan.
  • Without a plan, a change that affects safety or effectiveness can need a new submission.
  • A plan covers only the modifications it describes, so it has to be written carefully.

For AI-device teams with a model roadmap, usually alongside a 510(k) or De Novo.

Not the right fit if

  • Your model is locked and no changes are planned
  • You need to decide on one change you are making now: the model-change assessment

Questions

›What does the FDA's guidance ask a plan to contain?
A description of the modifications, a modification protocol with the methods and acceptance criteria each will be tested against, and an impact assessment. A plan keeps the device within its intended use.
›Does a plan mean the FDA will authorize our changes?
No. The FDA decides on the plan as part of the submission. Every deliverable says so on its cover.
›What isn't included in the price?
The FDA's own fees, testing, and clinical or statistical sign-off, which stay with you.
›Can a consultant buy it for a client?
Yes, at 20% off, under your firm’s name. How it works for consultants →
The change-control plan section · From $6,000the fee for your device is fixed in writing before work startsStart with a free first read